본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

Fimasartan attenuates renal ischemia-reperfusion injury by modulating inflammation-related apoptosis

이용수 9

영문명
Fimasartan attenuates renal ischemia-reperfusion injury by modulating inflammation-related apoptosis
발행기관
대한생리학회-대한약리학회
저자명
Jang-Hee Cho Soon-Youn Choi Hye-Myung Ryu Eun-Joo Oh Ju-Min Yook Ji-Sun Ahn Hee-Yeon Jung Ji-Young C
간행물 정보
『The Korean Journal of Physiology & Pharmacology』제22권 제6호, 661~670쪽, 전체 10쪽
주제분류
의약학 > 의학일반
파일형태
PDF
발행일자
2018.11.30
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Fimasartan, a new angiotensin II receptor antagonist, reduces myocyte damage and stabilizes atherosclerotic plaque through its anti-inflammatory effect in animal studies. We investigated the protective effects of pretreatment with fimasartan on ischemia-reperfusion injury (IRI) in a mouse model of ischemic renal damage. C57BL/6 mice were pretreated with or without 5 (IR-F5) or 10 (IR-F10) mg/kg/day fimasartan for 3 days. Renal ischemia was induced by clamping bilateral renal vascular pedicles for 30 min. Histology, pro-inflammatory cytokines, and apoptosis assays were evaluated 24 h after IRI. Compared to the untreated group, blood urea nitrogen and serum creatinine levels were significantly lower in the IR-F10 group. IR-F10 kidneys showed less tubular necrosis and interstitial fibrosis than untreated kidneys. The expression of F4/80, a macrophage infiltration marker, and tumor necrosis factor (TNF)-α, decreased in the IR-F10 group. High-dose fimasartan treatment attenuated the upregulation of TNF-α, interleukin (IL)-1β, and IL-6 in ischemic kidneys. Fewer TUNEL positive cells were observed in IR-F10 compared to control mice. Fimasartan caused a significant decrease in caspase-3 activity and the level of Bax, and increased the Bcl-2 level. Fimasartan preserved renal function and tubular architecture from IRI in a mouse ischemic renal injury model. Fimasartan also attenuated upregulation of inflammatory cytokines and decreased apoptosis of renal tubular cells. Our results suggest that fimasartan inhibited the process of tubular injury by preventing apoptosis induced by the inflammatory pathway.

목차

INTRODUCTION
METHODS
RESULTS
DISCUSSION
ACKNOWLEDGEMENTS
CONFLICTS OF INTEREST

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

Jang-Hee Cho,Soon-Youn Choi,Hye-Myung Ryu,Eun-Joo Oh,Ju-Min Yook,Ji-Sun Ahn,Hee-Yeon Jung,Ji-Young C. (2018).Fimasartan attenuates renal ischemia-reperfusion injury by modulating inflammation-related apoptosis. The Korean Journal of Physiology & Pharmacology, 22 (6), 661-670

MLA

Jang-Hee Cho,Soon-Youn Choi,Hye-Myung Ryu,Eun-Joo Oh,Ju-Min Yook,Ji-Sun Ahn,Hee-Yeon Jung,Ji-Young C. "Fimasartan attenuates renal ischemia-reperfusion injury by modulating inflammation-related apoptosis." The Korean Journal of Physiology & Pharmacology, 22.6(2018): 661-670

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제